Skip to content
Homepage
Author:
Priavoid GmbH
Posted Date:
March 19, 2026
Priavoid Presents Preclinical Proof-of-Concept for PRI-101 Demonstrating α-synuclein Aggregate Disassembly at AD/PD™ 2026
Priavoid GmbH
March 19, 2026
Priavoid Presents Initial Phase 2 Data Suggesting Favorable Safety Profile for Alzheimer’s Candidate PRI-002 at AD/PD™ 2026
Priavoid GmbH
March 17, 2026
Priavoid to Present Initial Phase 2 Safety Data for Alzheimer‘s and Preclinical PoC for Parkinson‘s Programs at AD/PD™ 2026
Priavoid GmbH
March 5, 2026
